HUM · Humana Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted (non-GAAP) consolidated pretax results non-GAAP | 2,918M | YTD 2026 | — |
|
|
|||
| Adjusted (non-GAAP) EPS non-GAAP | $17.91 | YTD 2026 | +4.5% |
|
|
|||
| CenterWell Senior Primary Care patients growth | 130,900 | YTD 2026 | +30.1% |
|
|
|||
| CenterWell Senior Primary Care patients growth percent | 27% | YTD 2026 | +8.0% |
|
|
|||
| Insurance segment GAAP benefit ratio | 91.2% | 2Q26 | — |
|
|
|||
| CenterWell Senior Primary Care MaxHealth acquired centers | 54 | 1Q26 | — |
| CenterWell Senior Primary Care MaxHealth acquired patients | 59,000 | 1Q26 | — |
| CenterWell Senior Primary Care patient growth | 110,500 | 1Q26 | — |
| State-based contracts membership growth | 50,000 | 1Q26 | — |
| Consolidated Adjusted (non-GAAP) benefit ratio non-GAAP | 90.2% | FY 2025 | — |
| Consolidated Adjusted (non-GAAP) operating cost ratio non-GAAP | 11.5% | FY 2025 | — |
| Insurance segment Adjusted (non-GAAP) benefit ratio non-GAAP | 90.4% | FY 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HUM
this stock
Humana Inc
|
$44.09B | +43.1% | +10.1% | 39.2 | 3.5% |
|
UNH
Unitedhealth Group Inc
|
$374.84B | +26.7% | +11.8% | 31.1 | 1.9% |
|
CVS
CVS HEALTH Corp
|
$123.06B | +27.8% | +10.9% | 25.4 | 1.5% |
|
ELV
Elevance Health, Inc.
|
$84.88B | +12.8% | +9.4% | 17.3 | 2.8% |
|
CI
Cigna Group
|
$72.73B | -0.6% | +11.2% | 11.4 | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HUM | -0.4% | -8.2% | +109.0% | 0.0% | +43.1% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -6.0% | -11.5% | +97.7% | -3.1% | +30.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.